ENDRA Life Sciences (NDRA) Net Shares Issued and Repurchased (2021 - 2026)

ENDRA Life Sciences (NDRA) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $52.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased rose 1633.33% year-over-year to $52.0 in Q1 2026; TTM through Mar 2026 was $52.0, a 1633.33% increase from a year earlier, with the FY2025 full-year figure at $42.0, up 7.69% from the prior year.
• Net Shares Issued and Repurchased was $52.0 for Q1 2026 at ENDRA Life Sciences, up from $42.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $2.8 million in Q1 2022 and troughed at $3.0 in Q1 2025.
• A 5-year average of $389083.1 and a median of $55346.0 in 2024 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased tumbled 99.99% in 2025 and soared 1633.33% in 2026, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $141975.0 in 2022, then soared by 93.08% to $274128.0 in 2023, then tumbled by 99.99% to $39.0 in 2024, then grew by 7.69% to $42.0 in 2025, then increased by 23.81% to $52.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $52.0 (Q1 2026), $42.0 (Q4 2025), and $3.0 (Q1 2025), per Business Quant data.